Cookie Consent
This site uses cookies to store information on your computer. Without consent certain enhanced features will not be available and future visits may require repeated consent, so it is recommended to accept the use of cookies. Visit the AHLA Privacy Policy for more information.
Schedule
|
11:00 am-12:15 pm | ||||
1. Data Governance: A Digital Economy Depends on Digital Trust
|
||||
12:30-1:30 pm | ||||
2. Connecting the Dots Between Health Apps, HIPAA, and the FTC
|
3. Preventing CyberHarm to Patients: Risk Management
|
4. Using Genomic Data in Health Care Research: Legal Considerations to Support Innovation
|
||
1:45-2:45 pm | ||||
5. Whose Data - De-identified Not Devalued Please join us for an important and illuminating discussion regarding issues related to “de-identified data” under HIPAA, which is also commonly referred to as anonymized data under other legal regimes. We plan to use concrete examples and fact patterns to talk through common issues and complications with de-identified data, both from a legal perspective with the two attorneys on our panel, but also from a practical perspective with our panel de-identification expert! Our presentation will include:
|
6. After A Cyber Attack: Trends and Enforcement Although cyber-attacks are becoming more and more common, the healthcare industry is still grappling with dealing with the aftermath of a breach. In this session, we will discuss:
|
7. The Responsible Use of AI in Health Care Advances in artificial intelligence (AI) have the potential to revolutionize the practice of medicine and health care, with potential uses ranging from precision medicine to improving many aspects of hospital administration. But the use of AI in health care also poses legal, ethical, equity, privacy and security risks. This panel will examine the challenges health care providers and health care companies are facing with respect to the use and development of AI. Topics will include:
|
||
3:00-4:15 pm | ||||
8. Interoperability and Information Blocking: Policy and Implementation
|
9. Lessons Learned from Covid Data Sharing Experience
|
10. The Health Data Gold Rush: Exploring the Legal, Operational, and Ethical Concerns of Data Monetization The evolution of technology and the ability to analyze data within the health care industry has led to various advancements, including an enhanced holistic view of patients, predicting health outcomes, shortening the time of diagnosis, and more effective treatments. These advancements in turn benefit patients and caregivers. However, large amounts of patient data are needed to fuel these advancements. As the need for patient data continues to grow, stewards of patient data are faced with an opportunity to monetize their data. Furthermore, as the value of health care data becomes understood, the FTC and other regulators will in turn scrutinize digital health transactions where acquisition of data is one of the primary reasons behind the transaction. This session will explore the following topics related to monetization of patient:
|
4:15-5:00 pm | ||
Networking Reception |
||
|
(Does not include Speaker Q&A; The on demand session will be available to watch on your own time) |
I. Agitations of Aggregated Data Sets
|
||||
II. Basics of Determining the FMV of Patient Health Data
|
||||
III. HIT Fraud and Abuse: Sprints, Relays, and Hurdles on the Road to Coordinated Care
|
Become a Sponsor
If your organization is interested in sponsoring and/or exhibiting at this program, please contact Valerie Eshleman.